This Gja4 (Cx37) knockout strain exhibits reduced bleeding times, rapid thrombus formation and lymphatic system structural irregularities. They may be useful in studies of gap junctional intercellular communication, vasculature development and ischemic injury recovery.
David L Paul, Harvard Medical School
Alexander Simon, University of Arizona
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Gja4 | gap junction protein, alpha 4 |
The Gja4 gene encodes an intercellular channel forming protein, also known as Connexin 37, that is a component of gap junctions. These mice carry a knock out mutation of the Gja4 gene in which a PGK-NEO cassette replaces almost the entire coding region. Homozygous females are viable but infertile due to absence of ovulation (oocyte and ovarian follicle development arrest). Homozygous males and heterozygous females are viable and fertile. No gene product (mRNA or protein) is detected by RT-PCR of heart tissue from homozygous E11.5 embryos, immunohistochemical analysis of oocytes, aorta tissue, kidney, and platelets, and by Western blot analysis of aortic endothelial lysates, from homozygotes. Homozygous animals have increased numbers of collateral blood vessels and recover more quickly from experimental hindlimb ischemic injury, and exhibit enhanced ischemia-induced collateral remodeling and angiogenesis, compared to wildtype controls. In addition, arteriolar conducted vasoconstriction in the cremaster muscle is reduced. Bleeding time is reduced in homozygotes, with more rapid thrombus formation and increased platelet aggregation. Homozygous embryos exhibit enlarged jugular lymph sacs (at E13.5), and have fewer numbers of lymphatic valves at later stages. Adult homozygotes have a deficiency in lymphatic valves, including thoracic duct valves, and exhibit lymphatic dysfunction (as measured by Evans Blue dye assay). Venous valves are absent in peripheral veins of homozygous mice. During backcrossing, the Y chromosome may not have been fixed to the C57BL/6 genetic background. Male mice that are homozygous for the targeted mutation are viable and fertile.
A targeting vector containing a PGK-NEO cassette was used to disrupt almost all of the coding region, excepting the first 77 bp. The construct was electroporated into 129S4/SvJae derived J1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts. The resulting chimeric animals were tested for germline transmission. The mice were then backcrossed to C57BL/6 for 6 generations. During backcrossing, the Y chromosome may not have been fixed to the C57BL/6 genetic background. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) at least once to establish the colony.
Allele Name | targeted mutation 1, David L Paul |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | Cx37- |
Gene Symbol and Name | Gja4, gap junction protein, alpha 4 |
Gene Synonym(s) | |
Strain of Origin | 129S4/SvJae |
Chromosome | 4 |
Molecular Note | The entire coding region except for the first 77 base pairs was replaced with a PGK-neo cassette. Immunostaining of homozygous mutant oocytes showed a lack of protein expression. |
When maintaining a live colony, heterozygous females and homozygous males can be bred. Homozygous females are infertile.
When using the B6.129S4-Gja4tm1Paul/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #025698 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or widltype for Gja4<tm1Paul> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.